The Medicare Advisory Payment Commission recommends a higher-than-current-law fee-for-service payment update in 2024 for acute care hospitals and positive payment updates for clinicians paid under the physician fee schedule.
Optum Health has named Caitlin Zulla CEO of the company’s East Region, promoting her after a three-year stint as CEO of SCA Health, a surgery center chain owned by Optum. Since joining in 2015 to lead revenue cycle operations, Zulla advanced to be Chief Financial Officer and Chief Administrative Officer prior to being CEO.
Aimee Cardwell, SVP and CISO at UnitedHealth Group, highlights her upcoming HIMSS23 presentation, focused on using your personnel and network to build resilience.
The White House and the Department of Health and Human Services have announced the names of the first set of Part B prescription drugs that will be subject to Medicare inflation rebates because they raised their prices faster than inflation. One of them is Humira, the AbbVie offering that treats arthritis. President Biden’s drug law […]
The Centers for Medicare and Medicaid Services on Wednesday released the parameters for the first year of prescription drug negotiations to lower prices in Medicare. The negotiations will affect only Medicare Part D for the first two years, for ten drugs during the first year and 15 in the second year, CMS said. After that, […]
Danish pharmaceutical company Novo Nordisk has announced it is lowering the U.S.
Insurers have been pushing back against a Medicare Advance Notice on payment rates and a Risk Adjustment Data Validation (RADV) final rule they say will affect consumers and taxpayers.
The Centers for Medicare and Medicaid Services has announced 27 prescription drugs for which Part B beneficiary coinsurances may be lower starting April 1 through June 30. Lower Part B coinsurance will go into effect on April 1 and will be reviewed quarterly. This coinsurance adjustment applies to certain drugs and biologicals covered under Medicare […]
Healthcare and technology groups want Medicare Advantage plans included in the Centers for Medicare and Medicaid Services’ proposed rule to expand access to health information and improve the prior authorization process.